Jeffrey C Liu, MD
Ophthalmology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 3
Offices
3 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Liu’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A94672 · Current
Licensed to practise in California · since 2006 · expires 2027-07-31 · Autonomous University of Guadalajara Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 036140181Licensed Physician And Surgeon · since 2016 · expires 2017-07-31InactiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$20,084
Medicare paid this office $20,084 for 13 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 11 | $2,493 | $76 |
Who their Medicare patients are
13 Original Medicare patients in 2024. Average age 63 · Health risk score 4.93. Sicker patients than 9 in 10 peers; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75%.
The office billed $63,424, Medicare allowed $26,698 and paid $20,084; for 140 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 13 | 140 | 63 | 4.93 | $63,424 | $20,084 |
| 2023 | 20 | 228 | 63 | 4.42 | $96,606 | $33,269 |
| 2022 | 14 | 194 | 62 | 4.90 | $103,840 | $38,011 |
| 2021 | 13 | 198 | 68 | 4.54 | $98,993 | $39,421 |
| 2020 | 13 | 138 | 64 | 3.82 | $75,327 | $25,629 |
| 2019 | 17 | 181 | 67 | 3.69 | $121,221 | $43,049 |
| 2018 | 17 | 123 | 66 | 4.07 | $54,151 | $11,718 |
| 2017 | 17 | 28 | 72 | 1.70 | $13,203 | $2,518 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Injection of drug into eye | 18 | $6,256 | $136 |
| Compounded drug, not otherwise classified | 16 | $3,857 | None |
| Short return visit (20+ min) | 12 | $3,150 | $85 |
| Imaging of retina | 11 | $1,057 | $35 |
2022: 1 service
| Injection of drug into eye | 12 | $4,997 | $139 |
2021: 1 service
| Injection of drug into eye | 11 | $5,870 | $154 |
2020: 2 services
| Injection of drug into eye | 11 | $3,153 | $102 |
| Imaging of retina | 13 | $1,282 | $39 |
2019: 1 service
| Imaging of retina | 16 | $1,861 | $39 |
2018: 1 service
| Imaging of retina | 13 | $1,555 | $35 |
Medicaid work
$78,928 in 2024
Medicaid paid $78,928 for 640 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Intravitreal injection of a pharmacologic agent (separate procedure) | 122 | $34,531 |
| Short return visit (20+ min) | 249 | $29,964 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 243 | $13,100 |
| Compounded drug, not otherwise classified | 13 | $957 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 13 | $375 |
| 2024 | 640 | 5 | 28 | $78,928 |
| 2023 | 812 | 4 | 30 | $1,803 |
| 2022 | 352 | 3 | 17 | $130 |
| 2021 | 423 | 4 | 20 | $219 |
| 2020 | 65 | 3 | 13 | $79 |
| 2019 | 13 | 1 | 12 | $0 |
See the largest Medicaid services in earlier years
2023
| Intravitreal injection of a pharmacologic agent (separate procedure) | 203 | $1,324 |
| Short return visit (20+ min) | 271 | $356 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 274 | $123 |
| Compounded drug, not otherwise classified | 64 | $0 |
2022
| Intravitreal injection of a pharmacologic agent (separate procedure) | 73 | $130 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 137 | $0 |
| Short return visit (20+ min) | 142 | $0 |
2021
| Intravitreal injection of a pharmacologic agent (separate procedure) | 98 | $153 |
| Compounded drug, not otherwise classified | 12 | $66 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 152 | $0 |
| Short return visit (20+ min) | 161 | $0 |
2020
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 40 | $79 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 12 | $0 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 13 | $0 |
2019
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 13 | $0 |
Drugs they prescribed that Part D paid
$38,482
Pharmacies billed $38,482 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 275) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
164 generic and 111 brand-name prescriptions · $38,482 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Nevanac | 16 | $23,324 | $1,458 |
| Cequa | 11 | $5,679 | $516 |
| Prednisolone Acetate | 84 | $5,179 | $62 |
| Ketorolac Tromethamine | 45 | $957 | $21 |
| Dorzolamide-Timolol | 31 | $734 | $24 |
See all 8 drugs
| Nevanac | 16 | $23,324 | $1,458 |
| Cequa | 11 | $5,679 | $516 |
| Prednisolone Acetate | 84 | $5,179 | $62 |
| Ketorolac Tromethamine | 45 | $957 | $21 |
| Dorzolamide-Timolol | 31 | $734 | $24 |
| Latanoprost | 31 | $410 | $13 |
| Erythromycin | 21 | $362 | $17 |
| Timolol Maleate | 12 | $302 | $25 |
Year by year
| 2024 | 275 | 93 | 0% (0) | 40% | $38,482 |
| 2023 | 208 | 78 | 0% (0) | 39% | $13,232 |
| 2022 | 186 | 58 | 0% (0) | 33% | $10,174 |
| 2021 | 282 | 104 | 0% (0) | 25% | $19,318 |
| 2020 | 300 | 116 | 0% (0) | 28% | $27,752 |
| 2019 | 537 | 192 | 0% (0) | 30% | $56,539 |
| 2018 | 682 | 286 | 0% (0) | 40% | $53,728 |
| 2017 | 724 | 269 | 0% (0) | 26% | $57,558 |
| 2016 | 1,244 | 374 | 0% (0) | 25% | $95,395 |
| 2015 | 1,250 | 423 | 0% (0) | 32% | $90,858 |
| 2014 | 2,019 | 518 | 0% (0) | 30% | $134,157 |
| 2013 | 2,065 | 518 | None | 36% | $108,501 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Cequa | 11 | $5,579 | $507 |
| Prednisolone Acetate | 68 | $3,788 | $56 |
| Dorzolamide-Timolol | 24 | $573 | $24 |
| Erythromycin | 19 | $460 | $24 |
| Dorzolamide | 15 | $448 | $30 |
| Ketorolac Tromethamine | 24 | $427 | $18 |
| Latanoprost | 13 | $201 | $15 |
2022: 6 drugs
| Cequa | 12 | $4,635 | $386 |
| Prednisolone Acetate | 44 | $2,161 | $49 |
| Erythromycin | 31 | $664 | $21 |
| Ketorolac Tromethamine | 29 | $506 | $17 |
| Dorzolamide-Timolol | 19 | $439 | $23 |
| Latanoprost | 15 | $260 | $17 |
2021: 8 drugs
| Prednisolone Acetate | 58 | $3,479 | $60 |
| Travoprost | 12 | $1,993 | $166 |
| Timolol Maleate | 17 | $1,293 | $76 |
| Ketorolac Tromethamine | 44 | $1,229 | $28 |
| Erythromycin | 33 | $676 | $20 |
| Dorzolamide-Timolol | 21 | $623 | $30 |
| Latanoprost | 29 | $537 | $19 |
| Brimonidine | 12 | $188 | $16 |
2020: 9 drugs
| Prednisolone Acetate | 61 | $3,084 | $51 |
| Travoprost | 13 | $2,122 | $163 |
| Dorzolamide-Timolol | 30 | $1,152 | $38 |
| Ketorolac Tromethamine | 34 | $891 | $26 |
| Latanoprost | 47 | $857 | $18 |
| Dorzolamide | 11 | $500 | $45 |
| Timolol Maleate | 12 | $481 | $40 |
| Erythromycin | 17 | $426 | $25 |
| Brimonidine | 19 | $316 | $17 |
2019: 12 drugs
| Restasis | 14 | $12,745 | $910 |
| Lumigan | 17 | $7,211 | $424 |
| Prednisolone Acetate | 74 | $4,140 | $56 |
| Travatan Z | 13 | $3,809 | $293 |
| Dorzolamide-Timolol | 68 | $3,231 | $48 |
| Latanoprost | 134 | $2,498 | $19 |
| Timolol Maleate | 20 | $1,187 | $59 |
| Ketorolac Tromethamine | 38 | $919 | $24 |
| Erythromycin | 27 | $892 | $33 |
| Dorzolamide | 17 | $719 | $42 |
| Brimonidine | 34 | $653 | $19 |
| Levobunolol | 11 | $158 | $14 |
2018: 10 drugs
| Prednisolone Acetate | 194 | $14,601 | $75 |
| Lumigan | 19 | $8,748 | $460 |
| Latanoprost | 158 | $4,183 | $26 |
| Dorzolamide-Timolol | 58 | $1,516 | $26 |
| Ketorolac Tromethamine | 56 | $1,264 | $23 |
| Brimonidine | 46 | $867 | $19 |
| Dorzolamide | 24 | $762 | $32 |
| Erythromycin | 22 | $563 | $26 |
| Timolol Maleate | 20 | $354 | $18 |
| Levobunolol | 17 | $266 | $16 |
2017: 11 drugs
| Lumigan | 38 | $15,441 | $406 |
| Latanoprost | 229 | $5,966 | $26 |
| Prednisolone Acetate | 69 | $5,154 | $75 |
| Travatan Z | 12 | $3,200 | $267 |
| Dorzolamide-Timolol | 104 | $3,196 | $31 |
| Brimonidine | 73 | $2,093 | $29 |
| Ketorolac Tromethamine | 21 | $838 | $40 |
| Dorzolamide | 23 | $803 | $35 |
| Timolol Maleate | 38 | $637 | $17 |
| Levobunolol | 34 | $542 | $16 |
| Erythromycin | 20 | $487 | $24 |
2016: 13 drugs
| Lumigan | 55 | $18,985 | $345 |
| Restasis | 30 | $18,000 | $600 |
| Latanoprost | 376 | $9,770 | $26 |
| Prednisolone Acetate | 91 | $6,460 | $71 |
| Travatan Z | 19 | $5,439 | $286 |
| Brimonidine | 148 | $5,409 | $37 |
| Dorzolamide-Timolol | 161 | $5,371 | $33 |
| Timolol Maleate | 70 | $1,534 | $22 |
| Dorzolamide | 46 | $1,505 | $33 |
| Erythromycin | 48 | $1,339 | $28 |
| Levobunolol | 73 | $1,281 | $18 |
| Diclofenac | 40 | $699 | $17 |
| Neomycin-Polymyxin-Dexameth | 14 | $330 | $24 |
2015: 14 drugs
| Restasis | 68 | $29,860 | $439 |
| Lumigan | 46 | $16,061 | $349 |
| Prednisolone Acetate | 203 | $15,323 | $75 |
| Latanoprost | 363 | $8,973 | $25 |
| Travatan Z | 14 | $3,995 | $285 |
| Erythromycin | 70 | $1,825 | $26 |
| Brimonidine | 51 | $1,499 | $29 |
| Ketorolac Tromethamine | 62 | $1,337 | $22 |
| Ofloxacin | 110 | $1,008 | $9 |
| Diclofenac | 46 | $868 | $19 |
| Neomycin-Polymyxin-Dexameth | 35 | $771 | $22 |
| Dorzolamide-Timolol | 30 | $728 | $24 |
| Levobunolol | 53 | $715 | $13 |
| Timolol Maleate | 25 | $449 | $18 |
2014: 14 drugs
| Restasis | 87 | $37,020 | $426 |
| Lumigan | 52 | $25,428 | $489 |
| Prednisolone Acetate | 267 | $19,745 | $74 |
| Latanoprost | 371 | $9,451 | $25 |
| Dorzolamide-Timolol | 173 | $5,678 | $33 |
| Travatan Z | 20 | $4,783 | $239 |
| Brimonidine | 133 | $3,440 | $26 |
| Diclofenac | 203 | $3,020 | $15 |
| Erythromycin | 92 | $2,638 | $29 |
| Timolol Maleate | 119 | $2,574 | $22 |
| Levobunolol | 132 | $1,909 | $14 |
| Ofloxacin | 205 | $1,729 | $8 |
| Dorzolamide | 48 | $1,313 | $27 |
| Neomycin-Polymyxin-Dexameth | 34 | $620 | $18 |
2013: 14 drugs
| Restasis | 87 | $29,911 | $344 |
| Lumigan | 46 | $17,415 | $379 |
| Prednisolone Acetate | 283 | $8,683 | $31 |
| Dorzolamide-Timolol | 165 | $7,975 | $48 |
| Latanoprost | 312 | $7,266 | $23 |
| Travatan Z | 24 | $5,290 | $220 |
| Brimonidine | 151 | $4,121 | $27 |
| Diclofenac | 223 | $3,303 | $15 |
| Timolol Maleate | 141 | $2,573 | $18 |
| Erythromycin | 78 | $2,049 | $26 |
| Dorzolamide | 71 | $2,012 | $28 |
| Levobunolol | 153 | $1,975 | $13 |
| Ofloxacin | 214 | $1,819 | $9 |
| Neomycin-Polymyxin-Dexameth | 21 | $495 | $24 |
Money from drug and device companies
$109 in 2022
| 2022 | 3 | 3 | None | $109 |
| 2021 | 2 | 2 | None | $34 |
| 2020 | 1 | 1 | None | $12 |
| 2019 | 3 | 3 | None | $162 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| CooperVision | Multiple Brands Contact Lens | $73 | 1 payment
|
| Allergan | Vuity | $20 | 1 payment
|
| Glaukos | Istent Inject W | $17 | 1 payment
|
See all 3 published payments
| Glaukos | Meals · 2022-11-22 | Istent Inject W | $17 |
| CooperVision | Meals · 2022-06-28 | Multiple Brands Contact Lens | $73 |
| Allergan | Meals · 2022-02-07 | Vuity | $20 |
See earlier years (2021, 2020, 2019)
2021: $34
| Allergan | Durysta | $20 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Lotemax Sm | $13 | 1 payment
|
2020: $12
| Bausch & Lomb a division of Bausch Health US | Prolensa | $12 | 1 payment
|
2019: $162
| Avedro | None | $126 | 1 payment
|
| Allergan | Restasis | $22 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Lotemax Sm | $14 | 1 payment
|
Professional record
- NPI
- 1851479422
- Licence
- CA A94672, IL 036140181California A94672: Current · expires 2027-07-31Illinois 036140181: Inactive
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 680 N Lake Shore Dr Ste 1000, Chicago, IL, 60611
- NPI first listed
- 2006-11-01
- NPI last updated
- 2021-12-09
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.